SARS-CoV-2 Antibody Prevalence and Population-Based Death Rates, Greater Omdurman, Sudan.
Abualas E
Bedri S
COVID-19
Elsir MT
Fahal MAH
Mohamed MFERO
Omdurman
SARS-CoV-2
Sudan
Sudan. Emerg Infect Dis. 2022 May [date cited]. https://doi.org/10.3201/eid2805.211951
Suggested citation for this article: Moser W
antibody
et al. SARS-CoV-2 antibody prevalence and population-based death rates
excess mortality
greater Omdurman
respiratory infections
seroprevalence
severe acute respiratory syndrome coronavirus 2
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
entrez:
22
4
2022
pubmed:
23
4
2022
medline:
26
4
2022
Statut:
ppublish
Résumé
In a cross-sectional survey in Omdurman, Sudan, during March-April 2021, we estimated that 54.6% of the population had detectable severe acute respiratory syndrome coronavirus 2 antibodies. Overall population death rates among those >50 years of age increased 74% over the first coronavirus disease pandemic year.
Identifiants
pubmed: 35450565
doi: 10.3201/eid2805.211951
pmc: PMC9045432
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1026-1030Références
Drug Discov Ther. 2020;14(4):153-160
pubmed: 32908070
Lancet Microbe. 2021 Jun;2(6):e240-e249
pubmed: 33778792
Front Med (Lausanne). 2020 Sep 02;7:569
pubmed: 32984390
Int J Infect Dis. 2021 Jan;102:483-488
pubmed: 33010461
Int J Infect Dis. 2021 Jan;102:118-122
pubmed: 33075535
PLoS One. 2021 Mar 4;16(3):e0247797
pubmed: 33661960
Emerg Infect Dis. 2022 Feb;28(2):429-431
pubmed: 35076007
Emerg Infect Dis. 2021 Jun;27(6):1598-1606
pubmed: 34013872
Cell Mol Immunol. 2021 Jul;18(7):1832-1834
pubmed: 34099890
Ann Clin Biochem. 2021 May;58(3):174-180
pubmed: 33334135
Nat Immunol. 2021 Jul;22(7):797-798
pubmed: 34035525